Skip to main content
Equibles
SKIN logo

SKIN · SkinHealth Systems Inc. · Webcasts, Transcripts & Audio

Track SKIN — free

Use SKIN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SKIN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.49 +0.37 (+3.66%) At close · Oct 28 Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$66.96M
Shares
6.51M
Volume · Oct 28 46.75K Avg daily vol (11 sessions) 53.44K

SkinHealth Systems Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for SkinHealth Systems Inc. (SKIN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY26 · Q3
2026-11-05
SkinHealth Systems Inc. (SKIN) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-06
SkinHealth Systems Inc. (SKIN) Q2 2026 Earnings Call Transcript
Balanced tone Hydrofacial Core Franchise Clinically Validated Boosters and Utilization Profitability and Margin Discipline
Revenue
$72.11M
▼ 7.8% YoY
Diluted EPS
$-0.40
▼ 166.7% YoY
Gross margin
68.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
SkinHealth Systems Inc. (SKIN) Q1 2026 Earnings Call Transcript
Cautious tone Consumables business Innovation pipeline Installed base and churn
Revenue
$64.91M
▼ 6.7% YoY
Diluted EPS
$-1.00
Gross margin
68.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-12
SkinHealth Systems Inc. (SKIN) Q4 2025 Earnings Call Transcript
Positive tone Consumables / boosters Installed base utilization shift Provider economics and commercial transformation
Revenue
$82.37M*
▼ 1.3% YoY
Gross margin
64.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-12-04
SkinHealth Systems Inc. (SKIN) Q3 2025 Earnings Call Transcript
Positive tone China distributor transition Macro and consumer weakness Churn in provider base
Revenue
$70.66M
▼ 10.3% YoY
Diluted EPS
$-1.80
Gross margin
64.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
SkinHealth Systems Inc. (SKIN) Q2 2025 Earnings Call Transcript
Confident tone Consumables and Razor-Razor Blade Model China Distributor Transition Margin Expansion and Cost Discipline
Revenue
$78.19M
▼ 13.7% YoY
Diluted EPS
$0.60
Gross margin
62.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
SkinHealth Systems Inc. (SKIN) Q1 2025 Earnings Call Transcript
Positive tone China distributor transition Consumables growth and recurring revenue Tariff exposure
Revenue
$69.58M
▼ 14.5% YoY
Diluted EPS
$-1.60
Gross margin
69.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-12
SkinHealth Systems Inc. (SKIN) Q4 2024 Earnings Call Transcript
Positive tone China distributor transition Consumables and boosters Cost discipline and profitability
Revenue
$83.50M*
▼ 13.8% YoY
Gross margin
62.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
SkinHealth Systems Inc. (SKIN) Q3 2024 Earnings Call Transcript
Balanced tone Consumables growth and gross margin Product innovation and HydraLoc HA Booster Macro headwinds and device sales pressure
Revenue
$78.80M
▼ 19.1% YoY
Diluted EPS
$-3.00
Gross margin
51.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
SkinHealth Systems Inc. (SKIN) Q2 2024 Earnings Call Transcript
Cautious tone Device sales recovery and capital equipment weakness Syndeo quality issues and replacement program Cost reduction and financial discipline
Revenue
$90.59M
▼ 22.9% YoY
Diluted EPS
$-2.00
▼ 433.3% YoY
Gross margin
45.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
SkinHealth Systems Inc. (SKIN) Q1 2024 Earnings Call Transcript
Positive tone Hydrafacial brand and provider relationships Guidance and financial outlook Syndeo device / capital equipment
Revenue
$81.40M
▼ 5.7% YoY
Diluted EPS
$-2.00
Gross margin
59.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-12
SkinHealth Systems Inc. (SKIN) Q4 2023 Earnings Call Transcript
Positive tone Provider and brand relationships Syndeo platform and quality issues Consumables growth and penetration
Revenue
$96.82M*
▼ 1.3% YoY
Gross margin
47.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
SkinHealth Systems Inc. (SKIN) Q3 2023 Earnings Call Transcript
Revenue
$97.41M
▲ 9.7% YoY
Diluted EPS
$-11.20
Gross margin
-12.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
SkinHealth Systems Inc. (SKIN) Q2 2023 Earnings Call Transcript
Revenue
$117.48M
▲ 13.5% YoY
Diluted EPS
$0.60
Gross margin
57.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
SkinHealth Systems Inc. (SKIN) Q1 2023 Earnings Call Transcript
Revenue
$86.28M
▲ 14.4% YoY
Diluted EPS
$-3.00
Gross margin
62.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
SkinHealth Systems Inc. (SKIN) Q4 2022 Earnings Call Transcript
Revenue
$98.13M*
▲ 26% YoY
Gross margin
67.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
SkinHealth Systems Inc. (SKIN) Q3 2022 Earnings Call Transcript
Revenue
$88.79M
▲ 30.3% YoY
Diluted EPS
$-0.60
Gross margin
69.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
SkinHealth Systems Inc. (SKIN) Q2 2022 Earnings Call Transcript
Revenue
$103.54M
▲ 55.7% YoY
Diluted EPS
$-1.20
Gross margin
67.6%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
SkinHealth Systems Inc. (SKIN) Q1 2022 Earnings Call Transcript
Revenue
$75.42M
▲ 58.6% YoY
Diluted EPS
$-2.60
Gross margin
67.5%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-22
SkinHealth Systems Inc. (SKIN) Q4 2021 Earnings Call Transcript
Revenue
$77.89M*
Gross margin
68.7%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-09
SkinHealth Systems Inc. (SKIN) Q3 2021 Earnings Call Transcript
Revenue
$68.15M
▲ 97.2% YoY
Diluted EPS
$-32.60
Gross margin
67.6%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
SkinHealth Systems Inc. (SKIN) Q2 2021 Earnings Call Transcript
Revenue
$66.51M
▲ 371.2% YoY
Diluted EPS
$-30.40
Gross margin
71.0%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
SkinHealth Systems Inc. (SKIN) Q1 2021 Earnings Call Transcript
Revenue
$47.54M
Diluted EPS
$-1.80
Gross margin
66.8%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–23 of 23 webcasts
Key facts CIK 1818093 CUSIP 88331L108 13F (30d) 8 filings 7 filers Visit website Investor relations